Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (2,839,224)	$ (5,390,213)
Adjustments to reconcile net loss to net cash used in operating activities
Bad debts	75,612
Depreciation and amortization	165,115	863,917
Amortization of right of use assets	131,858	134,455
Gain from early lease termination		(1,064)
Stock based compensation for services	330,000	1,886,793
Treasury stock	487,240
Written-off of fixed assets	8,461
Deferred tax assets	4,611
Accounts receivable	(75,522)	93,216
Inventories	51,747	81,922
Deposits, prepayments and other receivables	323,388	768,803
Contract assets	126,909	15,239
Contract liabilities	4,467	(140,365)
Accounts payables	137,303	166,895
Accrued liabilities and other payables	(1,129,221)	(2,376,133)
Advances to related parties	(333)	(65)
Operating lease liabilities	(163,897)	(118,601)
Net cash used in operating activities	(2,361,485)	(4,015,201)
Cash flows from investing activities:
Purchase of property, plant, and equipment		(190,061)
Net cash used in investing activities		(190,061)
Cash flows from financing activities:
Repurchase of common share	(487,240)	(541,988)
Proceed from the Sale of treasury stock	476,961
Net cash used in financing activities	(10,279)	(541,988)
Effect on exchange rate change on cash and cash equivalents	321,014	(428,145)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(2,050,750)	(5,175,395)
CASH AND CASH EQUIVALENT AT BEGINNING OF YEAR	3,723,982	19,003,336
CASH AND CASH EQUIVALENT AT END OF YEAR	1,673,232	13,827,941
Supplemental disclosure of cash flow information:
Cash paid for interest	173
Cash paid for income tax
Reconciliation to amounts on condensed unaudited consolidated balance sheets:
Cash and cash equivalents	1,619,232	13,755,377
Restricted cash	54,000	72,564
Total cash, cash equivalents and restricted cash	$ 1,673,232	$ 13,827,941